Intervention Review

Platinum containing regimens for metastatic breast cancer

  1. Sue Carrick1,*,
  2. Davina Ghersi2,
  3. Nicholas Wilcken3,
  4. John Simes4

Editorial Group: Cochrane Breast Cancer Group

Published Online: 19 APR 2004

Assessed as up-to-date: 2 MAY 2003

DOI: 10.1002/14651858.CD003374.pub3


How to Cite

Carrick S, Ghersi D, Wilcken N, Simes J. Platinum containing regimens for metastatic breast cancer. Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD003374. DOI: 10.1002/14651858.CD003374.pub3.

Author Information

  1. 1

    The National Breast Cancer Foundation, Research Strategy, Sydney, NSW, Australia

  2. 2

    National Health and Medical Research Council, Research Translation Group, Canberra, ACT, Australia

  3. 3

    Westmead and Nepean Hospitals, Medical Oncology, Westmead, NSW, Australia

  4. 4

    The University of Sydney, NHMRC Clinical Trials Centre, Camperdown, NSW, Australia

*Sue Carrick, Research Strategy, The National Breast Cancer Foundation, GPO Box 4126, Sydney, NSW, 2001, Australia. sue.carrick@nbcf.org.au.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 APR 2004

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Fikri Icli, Hakan Akbulut, Handan Onur, Bulent Yalcin, Ahmet Demirkazık, Filiz Çay Şenler, Adjuvant oral etoposide plus cisplatin (EoP) following sequential doxorubicin/cyclophosphamide (AC) and docetaxel (T) in early breast cancer patients with 4 or more positive lymph nodes (10 years follow-up), The Breast, 2011, 20, 2, 155

    CrossRef

  2. 2
    Emilie Lermite, Ettore Marzano, Elisabeth Chéreau, Roman Rouzier, Patrick Pessaux, Surgical resection of liver metastases from breast cancer, Surgical Oncology, 2010, 19, 4, e79

    CrossRef

  3. 3
    Windy Dean-Colomb, Francisco J. Esteva, Emerging Agents in the Treatment of Anthracycline- and Taxane-Refractory Metastatic Breast Cancer, Seminars in Oncology, 2008, 35, S31

    CrossRef

  4. 4
    Gary A. Quamme, Karl P. Schlingmann, Martin Konrad, Seldin and Giebisch's The Kidney, 2008,

    CrossRef

  5. 5
    Frank M. Senecal, Lorrin Yee, Nashat Gabrail, Veena Charu, Dianne Tomita, Greg Rossi, Lee Schwartzberg, Treatment of Chemotherapy-Induced Anemia in Breast Cancer: Results of a Randomized Controlled Trial of Darbepoetin Alfa 200 μg Every 2 Weeks Versus Epoetin Alfa 40,000 U Weekly, Clinical Breast Cancer, 2005, 6, 5, 446

    CrossRef